[1]
“Identification of a Papain-Like Protease Inhibitor with Potential for Repurposing in Combination with an Mpro Protease Inhibitor for Treatment of SARS-CoV-2”, acbr, vol. 6, no. 6, pp. 993–1002, Dec. 2022, Accessed: Sep. 17, 2026. Available: https://fortunejournals.org/ojs/index.php/acbr/article/view/14979